Springer, Clinical Drug Investigation, 8(32), p. 539-545, 2012
DOI: 10.2165/11633560-000000000-00000
Springer Verlag, Clinical Drug Investigation, 8(32), p. 539-545
DOI: 10.1007/bf03261907
Export citation
Search in Google Scholar
Full text: Unavailable